Copy to clipboard 
SpiTrex Orthopedics, a leading CMO in spine, trauma and extremities, today announced that Wade Berger has been appointed as the new Chief Executive Officer of the Group and will return as the site leader of SpiTrex CTE.
Mr. Berger brings a wealth of experience to SpiTrex, having previously served in various leadership roles at CTE for over 35 years, the last ten of them as site President. During his tenure at CTE, Mr. Berger successfully grew the company, demonstrating strong leadership and a vision for innovation while maintaining a customer-centric approach.
“We are thrilled to welcome Wade Berger as our new CEO,” said Jean-Marc Scéo, Chairman of the Board. “Wade’s extensive experience and proven track record make him the ideal person to lead SpiTrex into its next phase of growth. We are confident that under Wade’s leadership, SpiTrex Orthopedics will continue to innovate and deliver outstanding results for our customers.”
“I am honored and excited to lead this incredible team,” said Wade Berger. “I plan to reinvigorate the sites’ entrepreneurial spirit on which they were built.” Mr. Berger reiterated his passion to emphasize the unique abilities and expertise of all four Spitrex sites.
SpiTrex Orthopedics is an international contract manufacturer with a specific focus on complex orthopedic implants for the Spine, Trauma, and Extremity markets (Spi.Tr.Ex.). Its multi-site footprint comprises four manufacturing locations: SpiTrex CTE (Plymouth, IN), SpiTrex MDI (Lancaster, PA), SpiTrex 3D (Carlsbad, CA) and SpiTrex Switzerland (Le Locle, CH). They believe that together they can positively impact lives, that success comes from integrity, serving others, and a relentless quest for perfection, and that all problems can be solved with dedication, creative thinking, and personal care.
Source: SpiTrex Orthopedics
